Παραπομπή APA

Leder, B. Z., Zapalowski, C., Hu, M., Hattersley, G., Lane, N. E., Singer, A. J., & Dore, R. K. (2019). Fracture and Bone Mineral Density Response by Baseline Risk in Patients Treated With Abaloparatide Followed by Alendronate: Results From the Phase 3 ACTIVExtend Trial. J Bone Miner Res.

Παραπομπή Chicago Style

Leder, Benjamin Z., Carol Zapalowski, Ming‐Yi Hu, Gary Hattersley, Nancy E. Lane, Andrea J. Singer, και Robin K. Dore. "Fracture and Bone Mineral Density Response By Baseline Risk in Patients Treated With Abaloparatide Followed By Alendronate: Results From the Phase 3 ACTIVExtend Trial." J Bone Miner Res 2019.

Παραπομπή MLA

Leder, Benjamin Z., et al. "Fracture and Bone Mineral Density Response By Baseline Risk in Patients Treated With Abaloparatide Followed By Alendronate: Results From the Phase 3 ACTIVExtend Trial." J Bone Miner Res 2019.

Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.